The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...
Because the risk of many conditions increases with age, doctors generally recommend more frequent lab testing as you get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback